Oliver Wright, solicitor at law firm LHS, says a new high court ruling means improved transparency and a clearer framework for companies operating under regulation by the Health Research Authority
The clinical trials industry needs a strong regulator. The public demands it and the organisations operating under its remit expect it. Being clear and transparent with its subjects is of fundamental importance for all regulators in the health and pharmaceutical sectors.